Physician profile
Albert E Eulano
NPI 1578778213
$4,330.81
in general payments reported to CMS, 2019-2025
33 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $159 · 2021: $222 · 2022: $1,193 · 2023: $386 · 2024: $733 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $610.05 | 2022 | |
| Smith+Nephew, INC. | $573.54 | 2019-2021 | |
| Amgen INC. | $382.38 | 2024-2025 | Krystexxa |
| Nevro Corp. | $306.83 | 2022-2023 | Senza |
| Mimedx Group, INC. | $181.52 | 2024 | |
| Wright Medical Technology, INC. | $170.89 | 2019 | |
| Medtronic Vascular, INC. | $161.28 | 2019 | |
| Paratek Pharmaceuticals, INC. | $155.01 | 2023 | Nuzyra |
| Horizon Therapeutics Plc | $152.87 | 2020-2021 | |
| Solventum Corporation | $145.67 | 2024 | Prevena |
| Cardiovascular Systems INC. | $145.60 | 2019 | |
| Curonix LLC | $138.98 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ossio INC | $124.08 | 2022 | |
| Acera Surgical, INC. | $119.01 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $117.64 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $108.14 | 2019 | |
| Kerecis Limited | $108.01 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $102.41 | 2021-2024 | |
| Polarityte, INC. | $98.36 | 2019 | |
| Djo, LLC | $57.67 | 2019-2022 | |
| Xtant Medical INC | $46.46 | 2024 | |
| Depuy Synthes Sales INC. | $44.52 | 2019 | |
| Bioventus LLC | $43.72 | 2021-2022 | |
| Abbott Laboratories | $39.54 | 2022-2023 | Prodigy |
| Biowound Solutions, INC. | $38.08 | 2024 | Bio-Connekt |
| Forte Bio-Pharma LLC | $35.63 | 2019 | |
| Advanced Oxygen Therapy INC. | $26.81 | 2021-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $23.18 | 2022 | |
| Alfasigma USA, INC. | $16.17 | 2021 | |
| Tactile Systems Technology INC | $15.19 | 2023 | Entre Plus, Flexitouch Plus |
| Orthofix Medical, INC. | $14.50 | 2019 | |
| International Rehabilitative Sciences, INC | $14.14 | 2025 | Rs-4i Plus With Intersperse |
| Integra Lifesciences Corporation | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Eulano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.